Gossamer Bio, Inc. (GOSS)
10.71
-0.22
(-2.01%)
USD |
NASDAQ |
Oct 02, 16:00
10.72
+0.01
(+0.09%)
After-Hours: 20:00
Gossamer Bio Max Drawdown (5Y) : 99.13% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.13% |
| August 31, 2026 | 99.09% |
| July 31, 2026 | 99.09% |
| June 30, 2026 | 98.95% |
| May 31, 2026 | 98.70% |
| April 30, 2026 | 98.21% |
| March 31, 2026 | 98.21% |
| February 28, 2026 | 98.21% |
| January 31, 2026 | 98.21% |
| December 31, 2025 | 98.21% |
| November 30, 2025 | 98.21% |
| October 31, 2025 | 98.21% |
| September 30, 2025 | 98.21% |
| August 31, 2025 | 98.21% |
| July 31, 2025 | 98.21% |
| June 30, 2025 | 98.21% |
| May 31, 2025 | 98.21% |
| April 30, 2025 | 98.21% |
| March 31, 2025 | 98.21% |
| February 28, 2025 | 98.21% |
| January 31, 2025 | 98.21% |
| December 31, 2024 | 98.21% |
| November 30, 2024 | 98.21% |
| October 31, 2024 | 98.21% |
| September 30, 2024 | 98.21% |
| Date | Value |
|---|---|
| August 31, 2024 | 98.21% |
| July 31, 2024 | 98.21% |
| June 30, 2024 | 98.21% |
| May 31, 2024 | 98.21% |
| April 30, 2024 | 98.21% |
| March 31, 2024 | 98.21% |
| February 29, 2024 | 98.21% |
| January 31, 2024 | 98.21% |
| December 31, 2023 | 98.21% |
| November 30, 2023 | 98.21% |
| October 31, 2023 | 98.21% |
| September 30, 2023 | 97.10% |
| August 31, 2023 | 96.41% |
| July 31, 2023 | 96.41% |
| June 30, 2023 | 96.41% |
| May 31, 2023 | 96.41% |
| April 30, 2023 | 96.41% |
| March 31, 2023 | 96.41% |
| February 28, 2023 | 93.54% |
| January 31, 2023 | 93.50% |
| December 31, 2022 | 93.50% |
| November 30, 2022 | 77.72% |
| October 31, 2022 | 77.72% |
| September 30, 2022 | 77.72% |
| August 31, 2022 | 77.72% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| United Therapeutics Corp. | 33.00% |
| Arbutus Biopharma Corp. | 84.78% |
| Kura Oncology, Inc. | 86.69% |
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Alnylam Pharmaceuticals, Inc. | 58.17% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -84.72 |
| Beta (5Y) | 2.206 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 111.6% |
| Historical Sharpe Ratio (5Y) | -0.5613 |
| Historical Sortino (5Y) | -0.967 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 46.13% |